SENDCon | 2022 | Orlando, Florida, USA and Online
Based on the rising rates of COVID-19 reported by the U.S. Centers for Disease Control, the Southeastern Neurodegenerative Disease Conference (SENDCon) — Sept. 27-30, 2021 in Orlando, USA and online — is postponed out of an abundance of caution for attendees. SENDCon will be rescheduled and a 2022 date will be announced on the conference webpage soon.
Individuals who have submitted an abstract will be contacted by Association staff and given the opportunity to withdraw or transfer their submission.
If you’ve registered to attend in person, a refund will be issued automatically in the coming weeks. No action is needed on your part to initiate the refund process.
SENDCon aims to build a network of collaboration among early career dementia researchers, scientists and students who work on Alzheimer’s disease, amyotrophic lateral sclerosis, chronic traumatic encephalopathy, frontotemporal dementias, Huntington’s disease, Parkinson’s disease, stroke, traumatic brain injury and other neurodegenerative disorders.
This hybrid conference, held virtually and in-person, will provide substantial opportunities for early career dementia researchers to give both oral and poster presentations alongside their senior colleagues, with the goal of cross-recruitment across participating institutions.
SENDCon focuses on the work of scientists in Alabama, Florida, Georgia, Kentucky, North Carolina, South Carolina, Tennessee, Virginia and Puerto Rico — though neuroscience researchers from outside the region are also invited to register and attend.
General questions: SENDCon@alz.org
Media questions: media@alz.org
Please note: If you’ve registered to attend in person, a refund will be issued automatically in the coming weeks. No action is needed on your part to initiate the refund process.
Date: 2022 dates coming soon
Location: Orlando, USA and online
Network and collaborate year-round with ISTAART, a global community of researchers of all career stages who are working to advance Alzheimer’s and dementia research.
JOIN ISTAART
